Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Illumina's Accelerator Program

Premium

Illumina has launched its Accelerator Program, a business accelerator that will focus on speeding up the time to market and lowering barriers to entry for individuals and start-ups that are developing next-generation sequencing applications.

Illumina will invite participants to a six-month program, where it will provide technology and business guidance as well as $100,000 in support, including access to sequencing systems and reagents and laboratory space at facilities in San Francisco. Initial investors include Yuri Milner and Silicon Valley Bank.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.